Becton Dickinson and Co (BDX) Stock Analysis
Verdict: WATCH (do not buy)
Pure-play MedTech focus and pharmacy robotics drive margin re-rating, but trading above analyst targets with 0 insider buys urges patience.
Investment score: 55/100
Analysis as of
Is Becton Dickinson and Co stock worth reviewing? The TradeMates thesis
TradeMates scores BDX at 55/100 (WATCH). While strategic repositioning and pharmacy robotics expansion improve long-term margins, current valuation above consensus analyst targets limits 90-day upside.
7-factor investment score
- Valuation: 48/100 (weight 20%)
- Financial Health: 55/100 (weight 15%)
- Technical Momentum: 78/100 (weight 15%)
- Earnings Quality: 72/100 (weight 15%)
- Insider Sentiment: 20/100 (weight 10%)
- Analyst Consensus: 42/100 (weight 10%)
- Risk-Adjusted Return: 58/100 (weight 15%)
Becton Dickinson and Co opportunities and risks
What speaks for BDX
- MedTech Pure-Play Transformation and Deleveraging
What speaks against BDX
- Elevated Debt Load and Liquidity Pressure
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| BDX | 59.7x | 2.6x | 15.7x | 46.1% | 4.5% | 4.8% |
| ABT | 38.0x | 3.7x | 21.1x | 57.1% | 9.7% | 4.9% |
| ISRG | 52.7x | 13.4x | 35.5x | 67.2% | 25.5% | 2.3% |
| SYK | 31.4x | 4.5x | 19.3x | 65.2% | 14.4% | 4.0% |
| BSX | 18.5x | 3.2x | 13.5x | 71.2% | 17.5% | 5.5% |
| EW | 51.2x | 7.9x | 31.1x | 78.0% | 15.4% | 2.8% |
| Peer median | 38.0x | 4.5x | 21.1x | 67.2% | 15.4% | 4.0% |
Frequently asked questions about Becton Dickinson and Co (BDX)
Is BDX stock a good investment?
The TradeMates model rates Becton Dickinson and Co as WATCH (do not buy) with an investment score of 55/100. TradeMates scores BDX at 55/100 (WATCH). While strategic repositioning and pharmacy robotics expansion improve long-term margins, current valuation above consensus analyst targets limits 90-day upside. This is algorithmic model output, not personal investment advice.
Is BDX stock a buy?
The TradeMates model verdict for BDX is WATCH (do not buy) with an investment score of 55/100. Treat this as a model signal to review, not a personal buy recommendation.